Compound ID | 827
Class: Oxazolidinone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Institute where first reported: | Pharmacia Corp. and Veriscor (Pfizer, USA) |
| Year first mentioned: | 2001 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Was part of a series to identify linezolid analogs, the program seems still active, however, this seem to have been superseded |
| External links: | |
| Citation: |